Publication | Closed Access
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
356
Citations
23
References
2003
Year
This study confirms that zoledronic acid could have an in vivo antiangiogenic property through a significant and long-lasting reduction in serum VEGF levels.
| Year | Citations | |
|---|---|---|
Page 1
Page 1